While we’re weary to promote any kind of ‘quick fix’ weight loss pill, the “Take Five to Live Light” campaign is something we’re a little more willing to get behind.
The campaign is part of a study that’s investigating a new weight loss drug called Contrave, which has been in development for the last several years.
Contrave is a combination of two medications – naltrexone and bupropion – which have long-been prescribed to patients to aid weight loss. While the two haven’t been found dangerous on their own, the study is seeking to confirm that pairing the two won’t have any adverse affects on patients.
Steven R. Smith, M.D., scientific director of the Florida Hospital, believes that most people can’t achieve long term weight loss through diet and exercise alone, saying “the Light Study is an important clinical research study evaluating the cardiovascular health outcomes of Contrave, which is designed to reduce appetite, increase metabolism, and control cravings and overeating behaviors.”
Read Full Post >